We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Customvis | LSE:CUS | London | Ordinary Share | GB0033220350 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.93 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
25/9/2009 11:00 | My two buys at sub 1.80p today not yet shown. | maytrees | |
22/9/2009 15:30 | hi bought some of these a while back and just been looking in over the past few days to see what's going. very quiet considering this has just broke though recent highs, does anyone own any. look to have a lot of potential, and still a tiny mkt cap | gimme sunshine | |
21/9/2009 08:26 | Looking forward to another good day today. | robandkerry | |
18/9/2009 18:14 | Dolores - thanks for that - wondered why the move | mikehardman | |
18/9/2009 15:20 | Dolores - good point, although I would rather hope that the movement is based on a favourable reception for the CEO's speach at the Congress of the European Society of Cataract and Refractive Surgeons (ESCRS). As robandkerry mentioned "If just 1% of the members place an order, thats 40 new machines." | pudpud | |
18/9/2009 11:49 | RHPS update says CustomVis has sold two more of its Pulsar Z1 solid state lasers for eye surgery. One of these is to Spain and the second to a customer that had previously received a free laser and has been providing surgical data. At the forthcoming Congress of the European Society of Cataract and Refractive Surgeons, chief executive Paul van Saarloos will be presenting evidence of the effectiveness of the Pulzar Z1 laser. Meanwhile, trials at the influential Moorfields Eye Hospital have now started and initial results should be available at the time of the annual results in November. BUY UP TO 2p. | dolores123 | |
18/9/2009 11:43 | Ahem, cough, splutter ....... but of course they went well. Who would ever doubt that they would. Phew did I get away with it? | pudpud | |
18/9/2009 09:11 | Looks like the presentation went well. :) Directors buying too. | robandkerry | |
17/9/2009 16:45 | This is the bit i was refering to ESCRS is Europe's leading organisation for the industry with over 4,000 members from 90 different countries. The Pulzar Z1 laser will also be exhibited to potential customers over the five day event. | robandkerry | |
17/9/2009 14:41 | Hmm given the lack of interest on this BB and the share price ..... maybe he did | pudpud | |
14/9/2009 16:58 | robandkerry Very interesting bit about the Congress - the CEO is hardly likely to say that the Pulzar Z1 is a pile of garbage, we've wasted a bunch of money and now we're back to the drawing board ..... is he? | pudpud | |
14/9/2009 16:06 | Showing up as a sell. | robandkerry | |
14/9/2009 15:10 | Added a few at 1.375p | maytrees | |
11/9/2009 12:47 | This is the bit i like. CustomVis will be attending the 27th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) between 12-16 September where Paul van Saarloos, the CEO of CustomVis, will present two papers on the clinical results of the Pulzar Z1 laser. At least two other papers are expected to be presented by other surgeons on this topic. ESCRS is Europe's leading organisation for the industry with over 4,000 members from 90 different countries. The Pulzar Z1 laser will also be exhibited to potential customers over the five day event. If just 1% of the members place an order, thats 40 new machines. | robandkerry | |
11/9/2009 12:27 | Trial hope for CustomVis | investinggarden | |
11/9/2009 12:04 | Level 2 2v1. Ready for blast off. :) | robandkerry | |
11/9/2009 10:13 | Great news for CUS. Results out soon which will be much better than market expectations. | robandkerry | |
11/9/2009 09:31 | Not sure if the original thread creator 'happyboys' still posts: is there any chance of getting some charts on the thread please? | pelleeds1980 | |
11/9/2009 09:00 | Back in at 1.40p In auction meanwhile | maytrees | |
11/9/2009 08:56 | good news - 2 more contracts, Moorfield trial going ahead (had been delayed by staffing problems there), presenting and demoing at week-long international conference now turned up from little wedge, where it had been gaining support from the rising 200MA looking for it to regain some of its prior hype&hope prices, everhopful! (see chart in preceding post) upcoming: - late October - finals - early November - initial results from Moorfields trials | mikehardman | |
24/7/2009 15:19 | good volume today, incl. a sizeable sell (remember it is only a small stock), and the subsequent move up suggests it was a bit of a clearance it has been a long hard road, but it is winning orders, and quicker now, and has the potential to grab a large part of its (niche) market, having only a smidge at the moment; a recent bit of feather-ruffling by rebel ex-dirs seems to have passed now (that probably explains the price slide from the 1.8p R level), so hopefully we can get back to selling the lasers, and progressing the other devices; an update on the Moorfields trials could be nice, too; finals late-Oct09, going on last year would be nice to regain some of its historical prices! even getting back up to 5p would make it a 4-bagger from here | mikehardman | |
09/7/2009 10:30 | ReSIPPed at 1.20p. EDIT and a few more at 1.15p. | maytrees | |
06/7/2009 13:47 | Sorry - typo loss of signal from brain to fingers. I read through all the proposals and voted against. No substance and the current team know what they can do and how they can increase the business substantially but with caution and planning - always somthing you want to hear. If I had more money available I would be banking more at that price as well. May have to take a loss on another to get on this one now! Should be up,up and away, as we know the next report should only be good. What with including the last cash laser into the financials and having a new cash stream on online already to be reported. | discoverytim | |
06/7/2009 13:08 | I SIPPed a few at 1.40p earlier and agree that sales from disgruntled former directors may have presented that buying opp. But DiscoveryTim, my reading is that the resolutions were all rejected rather than all passed as you post indicates. Did you want them passsed or was that a mistype?? | maytrees | |
06/7/2009 13:01 | So the resolution is passed (as was needed: imho) and we have a drop with the sell off. This must only be from the disgruntled former directors selling out and good riddance. The new management team are taking this company back to where it should be and we continue to have perfect sales updates. Costs are way down from the previous management team and production is up. Just go to be strong and keep our nerve for the interim as this should really take hold now that all the external issue are resolved once and for all. A positive cash flow and orders continuing to come in only looks rosey for all. | discoverytim |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions